fig1
Figure 1. Immunohistochemistry for PDL1. Here a squamous cell carcinoma to almost 100% positive for PDL1. This would be an ideal candidate for the PDL1 antibody therapy. Bar 20 µm. PDL1: programmed death ligand 1
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Navigation
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Follow OAE
